Gene-expression profiling predicts recurrence in Dukes' C colorectal cancer

Gastroenterology

Volumn 129, Issue 3, 2005, Pages 874-884

  Arango, Diego ^a,b,g   Laiho, Paivi ^a   Kokko, Antti ^a   Alhopuro, Pia ^a   Sammalkorpi, Heli ^a   Salovaara, Reijo ^a,c   Nicorici, Daniel ^d   Hautaniemi, Sampsa ^d   Alazzouzi, Hafid ^b   Mecklin, Jukka Pekka ^e   Järvinen, Heikki ^c   Hemminki, Akseli ^a,f   Astola, Jaakko ^d   Schwartz Jr , Simo ^b   Aaltonen, Lauri A ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c UNIVERSITY OF HELSINKI   (Finland)

^d TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^e JYVÄSKYLÄ CENTRAL HOSPITAL   (Finland)

^f HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^g HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALLELE; ARTICLE; CANCER CLASSIFICATION; CANCER SURGERY; CANCER SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; DNA MICROARRAY; FROZEN SECTION; GENE EXPRESSION; GENE MUTATION; GENETIC MARKER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN FOLDING; PROTEIN TRANSPORT; RECURRENT CANCER;

EID: 24144469347     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2005.06.066     Document Type: Article

References (57)

1. C.G. Moertel, T.R. Fleming, J.S. Macdonald, D.G. Haller, J.A. Laurie, P.J. Goodman, J.S. Ungerleider, W.A. Emerson, D.C. Tormey, J.H. Glick Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma N Engl J Med 322 1990 352 358
2. C.G. Moertel, T.R. Fleming, J.S. Macdonald, D.G. Haller, J.A. Laurie, C.M. Tangen, J.S. Ungerleider, W.A. Emerson, D.C. Tormey, J.H. Glick Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma a final report Ann Intern Med 122 1995 321 326
3. S.M. Bell, N. Scott, D. Cross, P. Sagar, F.A. Lewis, G.E. Blair, G.R. Taylor, M.F. Dixon, P. Quirke Prognostic value of p53 overexpression and c-Ki-ras gene mutations in colorectal cancer Gastroenterology 104 1993 57 64
4. J. Benhattar, L. Losi, P. Chaubert, J.C. Givel, J. Costa Prognostic significance of K-ras mutations in colorectal carcinoma Gastroenterology 104 1993 1044 1048
5. H.S. Goh, J. Yao, D.R. Smith p53 point mutation and survival in colorectal cancer patients Cancer Res 55 1995 5217 5221
6. O.A. Ogunbiyi, P.J. Goodfellow, K. Herfarth, G. Gagliardi, P.E. Swanson, E.H. Birnbaum, T.E. Read, J.W. Fleshman, I.J. Kodner, J.F. Moley Confirmation that chromosome 18q allelic loss in colon cancer is a prognostic indicator J Clin Oncol 16 1998 427 433
7. G. Lanza, M. Matteuzzi, R. Gafa, E. Orvieto, I. Maestri, A. Santini, L. del Senno Chromosome 18q allelic loss and prognosis in stage II and III colon cancer Int J Cancer 79 1998 390 395
8. T. Watanabe, T.T. Wu, P.J. Catalano, T. Ueki, R. Satriano, D.G. Haller, A.B. Benson III, S.R. Hamilton Molecular predictors of survival after adjuvant chemotherapy for colon cancer N Engl J Med 344 2001 1196 1206
9. P. Laurent-Puig, S. Olschwang, O. Delattre, Y. Remvikos, B. Asselain, T. Melot, P. Validire, M. Muleris, J. Girodet, R.J. Salmon Survival and acquired genetic alterations in colorectal cancer Gastroenterology 102 1992 1136 1141
10. J. Jen, H. Kim, S. Piantadosi, Z.F. Liu, R.C. Levitt, P. Sistonen, K.W. Kinzler, B. Vogelstein, S.R. Hamilton Allelic loss of chromosome 18q and prognosis in colorectal cancer N Engl J Med 331 1994 213 221
11. C.B. Diep, L. Thorstensen, G.I. Meling, E. Skovlund, T.O. Rognum, R.A. Lothe Genetic tumor markers with prognostic impact in Dukes' stages B and C colorectal cancer patients J Clin Oncol 21 2003 820 829
12. K.H. Cohn, D.L. Ornstein, F. Wang, F.D. LaPaix, K. Phipps, C. Edelsberg, R. Zuna, L.A. Mott, J.L. Dunn The significance of allelic deletions and aneuploidy in colorectal carcinoma. Results of a 5-year follow-up study Cancer 79 1997 233 244
13. M. Schena, D. Shalon, R.W. Davis, P.O. Brown Quantitative monitoring of gene expression patterns with a complementary DNA microarray Science 270 1995 467 470
14. L.H. Augenlicht, D. Kobrin Cloning and screening of sequences expressed in a mouse colon tumor Cancer Res 42 1982 1088 1093
15. L. Wodicka, H. Dong, M. Mittmann, M.H. Ho, D.J. Lockhart Genome-wide expression monitoring in Saccharomyces cerevisiae Nat Biotechnol 15 1997 1359 1367
16. M. Mahadevappa, J.A. Warrington A high-density probe array sample preparation method using 10- to 100-fold fewer cells Nat Biotechnol 17 1999 1134 1136
17. T.R. Golub, D.K. Slonim, P. Tamayo, C. Huard, M. Gaasenbeek, J.P. Mesirov, H. Coller, M.L. Loh, J.R. Downing, M.A. Caligiuri, C.D. Bloomfield, E.S. Lander Molecular classification of cancer class discovery and class prediction by gene expression monitoring Science 286 1999 531 537
18. A.A. Alizadeh, M.B. Eisen, R.E. Davis, C. Ma, I.S. Lossos, A. Rosenwald, J.C. Boldrick, H. Sabet, T. Tran, X. Yu, J.I. Powell, L. Yang, G.E. Marti, T. Moore, J. Hudson Jr, L. Lu, D.B. Lewis, R. Tibshirani, G. Sherlock, W.C. Chan, T.C. Greiner, D.D. Weisenburger, J.O. Armitage, R. Warnke, L.M. Staudt Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling Nature 403 2000 503 511
19. C. Kihara, T. Tsunoda, T. Tanaka, H. Yamana, Y. Furukawa, K. Ono, O. Kitahara, H. Zembutsu, R. Yanagawa, K. Hirata, T. Takagi, Y. Nakamura Prediction of sensitivity of esophageal tumors to adjuvant chemotherapy by cDNA microarray analysis of gene-expression profiles Cancer Res 61 2001 6474 6479
20. Y. Wang, T. Jatkoe, Y. Zhang, M.G. Mutch, D. Talantov, J. Jiang, H.L. McLeod, D. Atkins Gene expression profiles and molecular markers to predict recurrence of Dukes' B colon cancer J Clin Oncol 22 2004 1564 1571
21. V.G. Tusher, R. Tibshirani, G. Chu Significance analysis of microarrays applied to the ionizing radiation response Proc Natl Acad Sci U S A 98 2001 5116 5121
22. B.R. Zeeberg, W. Feng, G. Wang, M.D. Wang, A.T. Fojo, M. Sunshine, S. Narasimhan, D.W. Kane, W.C. Reinhold, S. Lababidi, K.J. Bussey, J. Riss, J.C. Barrett, J.N. Weinstein GoMiner a resource for biological interpretation of genomic and proteomic data Genome Biol 4 2003 R28
23. M.B. Eisen, P.T. Spellman, P.O. Brown, D. Botstein Cluster analysis and display of genome-wide expression patterns Proc Natl Acad Sci U S A 95 1998 14863 14868
24. S.P. Lloyd Least square quantization in PCM Trans Information Theory IT-28 1982 129 137
25. D. Arango, A.J. Wilson, Q. Shi, G.A. Corner, M.J. Arañes, C. Nicholas, M. Lesser, J.M. Mariadason, L.H. Augenlicht Molecular mechanisms of action and prediction of response to oxaliplatin in colorectal cancer cells Br J Cancer 91 2004 1931 1946
26. J.M. Mariadason, D. Arango, Q. Shi, A.J. Wilson, G.A. Corner, C. Nicholas, M.J. Aranes, M. Lesser, E.L. Schwartz, L.H. Augenlicht Gene expression profiling-based prediction of response of colon carcinoma cells to 5-fluorouracil and camptothecin Cancer Res 63 2003 8791 8812
27. D. Arango, J.M. Mariadason, A.J. Willson, W. Yang, G.A. Corner, M.J. Arañes, C. Nicholas, L.H. Augenlicht c-Myc overexpression sensitizes colon cancer cells to camptothecin-induced apoptosis Br J Cancer 89 2003 1757 1765
28. Alhopuro P, Alazzouzi H, Sammalkorpi H, Salovaara R, Hemminki A, Järvinen H, Mecklin JP, Aaltonen LA, Arango D. SMAD4 levels and response to 5-fluorouracil in colorectal cancer. Clin Cancer Res (in press).
29. K. Servomaa, A. Kiuru, V.M. Kosma, P. Hirvikoski, T. Rytomaa p53 and K-ras gene mutations in carcinoma of the rectum among Finnish women Mol Pathol 53 2000 24 30
30. P. Laiho, V. Launonen, P. Lahermo, M. Esteller, M. Guo, J.G. Herman, J.P. Mecklin, H. Jarvinen, P. Sistonen, K.M. Kim, D. Shibata, R.S. Houlston, L.A. Aaltonen Low-level microsatellite instability in most colorectal carcinomas Cancer Res 62 2002 1166 1170
31. I.C. Hsu, R.A. Metcalf, T. Sun, J.A. Welsh, N.J. Wang, C.C. Harris Mutational hotspot in the p53 gene in human hepatocellular carcinomas Nature 350 1991 427 428
32. H. Alazzouzi, P. Alhopuro, R. Salovaara, H. Sammalkorpi, H. Järvinen, J.P. Mecklin, S.J. Schwartz, L.A. Aaltonen, D. Arango SMAD4 as a prognostic marker in colorectal cancer Clin Cancer Res 11 2005 2606 2611
33. F. Canzian, R. Salovaara, A. Hemminki, P. Kristo, R. Chadwick, L. Aaltonen, A. de la Chapelle Semiautomated assessment of loss of heterozygosity and replication error in tumors Cancer Res 56 1996 3331 3337
34. A. Horiuchi, T. Imai, C. Wang, S. Ohira, Y. Feng, T. Nikaido, I. Konishi Up-regulation of small GTPases, RhoA and RhoC, is associated with tumor progression in ovarian carcinoma Lab Invest 83 2003 861 870
35. J.M. Mariadason, D. Arango, G.A. Corner, M.J. Aranes, K.A. Hotchkiss, W. Yang, L.H. Augenlicht A gene expression profile that defines colon cell maturation in vitro Cancer Res 62 2002 4791 4804
36. S. Rihet, P. Vielh, J. Camonis, B. Goud, S. Chevillard, J. de Gunzburg Mutation status of genes encoding RhoA, Rac1, and Cdc42 GTPases in a panel of invasive human colorectal and breast tumors J Cancer Res Clin Oncol 127 2001 733 738
37. J.A. Moscow, R. He, J.R. Gnarra, T. Knutsen, Y. Weng, W.P. Zhao, J. Whang-Peng, W.M. Linehan, K.H. Cowan Examination of human tumors for rhoA mutations Oncogene 9 1994 189 194
38. K.W. Cheng, J.P. Lahad, W.L. Kuo, A. Lapuk, K. Yamada, N. Auersperg, J. Liu, K. Smith-McCune, K.H. Lu, D. Fishman, J.W. Gray, G.B. Mills The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers Nat Med 10 2004 1251 1256
39. M. Fukata, K. Kaibuchi Rho-family GTPases in cadherin-mediated cell-cell adhesion Nat Rev Mol Cell Biol 2 2001 887 897
40. T.R. Kau, J.C. Way, P.A. Silver Nuclear transport and cancer from mechanism to intervention Nat Rev Cancer 4 2004 106 117
41. C. Garrido, S. Gurbuxani, L. Ravagnan, G. Kroemer Heat shock proteins endogenous modulators of apoptotic cell death Biochem Biophys Res Commun 286 2001 433 442
42. R.V. Rao, H.M. Ellerby, D.E. Bredesen Coupling endoplasmic reticulum stress to the cell death program Cell Death Differ 11 2004 372 380
43. G. Brunagel, U. Shah, R.E. Schoen, R.H. Getzenberg Identification of calreticulin as a nuclear matrix protein associated with human colon cancer J Cell Biochem 89 2003 238 243
44. A. Schubert, S. Grimm Cyclophilin D, a component of the permeability transition-pore, is an apoptosis repressor Cancer Res 64 2004 85 93
45. S. Xanthoudakis, S. Roy, D. Rasper, T. Hennessey, Y. Aubin, R. Cassady, P. Tawa, R. Ruel, A. Rosen, D.W. Nicholson Hsp60 accelerates the maturation of pro-caspase-3 by upstream activator proteases during apoptosis EMBO J 18 1999 2049 2056
46. J.M. Han, J.Y. Kim, S. Kim Molecular network and functional implications of macromolecular tRNA synthetase complex Biochem Biophys Res Commun 303 2003 985 993
47. C. Francklyn, J.J. Perona, J. Puetz, Y.M. Hou Aminoacyl-tRNA synthetases versatile players in the changing theater of translation RNA 8 2002 1363 1372
48. J.L. Bos ras oncogenes in human cancer a review Cancer Res 49 1989 4682 4689
49. C. Oliveira, J.L. Westra, D. Arango, M. Ollikainen, E. Domingo, A. Ferreira, S. Velho, R. Niessen, K. Lagerstedt, P. Alhopuro, P. Laiho, I. Veiga, M.R. Teixeira, M. Ligtenberg, J.H. Kleibeuker, R.H. Sijmons, J.T. Plukker, K. Imai, P. Lage, R. Hamelin, C. Albuquerque, S. Schwartz Jr, A. Lindblom, P. Peltomaki, H. Yamamoto, L.A. Aaltonen, R. Seruca, R.M. Hofstra Distinct patterns of KRAS mutations in colorectal carcinomas according to germline mismatch repair defects and hMLH1 methylation status Hum Mol Genet 13 2004 2303 2311
50. A.B. Jaffe, A. Hall Rho GTPases in transformation and metastasis Adv Cancer Res 84 2002 57 80
51. E. Vial, E. Sahai, C.J. Marshall ERK-MAPK signaling coordinately regulates activity of Rac1 and RhoA for tumor cell motility Cancer Cell 4 2003 67 79
52. E.A. Cox, S.K. Sastry, A. Huttenlocher Integrin-mediated adhesion regulates cell polarity and membrane protrusion through the Rho family of GTPases Mol Biol Cell 12 2001 265 277
53. A. de Gramont, A. Figer, M. Seymour, M. Homerin, A. Hmissi, J. Cassidy, C. Boni, H. Cortes-Funes, A. Cervantes, G. Freyer, D. Papamichael, N. Le Bail, C. Louvet, D. Hendler, F. de Braud, C. Wilson, F. Morvan, A. Bonetti Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer J Clin Oncol 18 2000 2938 2947
54. S. Giacchetti, B. Perpoint, R. Zidani, N. Le Bail, R. Faggiuolo, C. Focan, P. Chollet, J.F. Llory, Y. Letourneau, B. Coudert, F. Bertheaut-Cvitkovic, D. Larregain-Fournier, A. Le Rol, S. Walter, R. Adam, J.L. Misset, F. Levi Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer J Clin Oncol 18 2000 136 147
55. D. Cunningham, S. Pyrhonen, R.D. James, C.J.A. Punt, T.F. Hickish, R. Heikkila, T.B. Johannesen, H. Starkhammar, C.A. Topham, L. Awad Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer Lancet 352 1998 1413 1418
56. J.Y. Douillard, D. Cunningham, A.D. Roth, M. Navarro, R.D. James, P. Karasek, P. Jandik, T. Iveson, J. Carmichael, M. Alakl, G. Gruia, L. Awad, P. Rougier Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer a multicentre randomised trial Lancet 355 2000 1041 1047
57. D. Arango, L.H. Augenlicht New approaches to colorectal cancer treatment. Recent research developments in cancer Volume 3 2001 Transworld Research Network Trivandrum, India 385 395